Global Contract Pharmaceutical Manufacturing Market Growth (Status and Outlook) 2024-2030
Contract Pharmaceutical Manufacturing market grows from US$85.45 billion in 2023 to US$129.51 billion by 2030, with a 6.1% CAGR, driven by increasing demand.
- Bonafide Trust
- 04-01-2024
- Pages : 128
- Figures : 77
- Tables : 142
- Region : Global
- Category : Lifescience
- Pharmaceutical
According to our publisher’s latest study, the global Contract Pharmaceutical Manufacturing market size was valued at US$ 85450 million in 2023. With growing demand in downstream market, the Contract Pharmaceutical Manufacturing is forecast to a readjusted size of US$ 129510 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Contract Pharmaceutical Manufacturing market. Contract Pharmaceutical Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contract Pharmaceutical Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contract Pharmaceutical Manufacturing market.
What's Inside a Bonafide Research`s industry report?
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleContract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing. Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%. North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent. In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise. Key Features:
The report on Contract Pharmaceutical Manufacturing market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Contract Pharmaceutical Manufacturing market. It may include historical data, market segmentation by Type (e.g., Oral, Injectable), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contract Pharmaceutical Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Contract Pharmaceutical Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Contract Pharmaceutical Manufacturing industry. This include advancements in Contract Pharmaceutical Manufacturing technology, Contract Pharmaceutical Manufacturing new entrants, Contract Pharmaceutical Manufacturing new investment, and other innovations that are shaping the future of Contract Pharmaceutical Manufacturing. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contract Pharmaceutical Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Contract Pharmaceutical Manufacturing product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contract Pharmaceutical Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contract Pharmaceutical Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contract Pharmaceutical Manufacturing market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contract Pharmaceutical Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contract Pharmaceutical Manufacturing market. Market Segmentation: Contract Pharmaceutical Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Contract Pharmaceutical Manufacturing Market Segmentation The Contract Pharmaceutical Manufacturing (CMO) market is segmented by two key factors: Type and Application. This segmentation helps understand market trends, product development, and target audiences. Here's a breakdown of each segment: Segmentation by Type: • Oral Dosage Forms: This is the largest segment, encompassing tablets, capsules, and pills. It caters to a wide range of medications and offers ease of administration for patients. • Injectable Products: These sterile dosage forms include solutions, suspensions, and emulsions delivered via injection. They are used for medications requiring rapid or targeted delivery. • Active Pharmaceutical Ingredients (APIs): APIs are the core components of a drug that produce the intended therapeutic effect. CMOs can manufacture bulk or finished APIs for pharmaceutical companies. Segmentation by Application: • Large Enterprises: Major pharmaceutical companies often outsource manufacturing activities like large-scale production, complex formulations, or specific dosage forms. This allows them to focus on drug discovery, clinical trials, and marketing. • Small and Medium Enterprises (SMEs): Smaller companies may lack the resources or infrastructure for in-house manufacturing. CMOs provide them with a cost-effective solution to produce their drugs and bring them to market. Regional Analysis • North America (Leader): Holds the top spot (over 40% share) due to: o Established pharmaceutical and biotech companies. o Stringent regulations requiring specialized expertise in CMOs. o High R&D spending focused on innovation. • Asia Pacific (Fast-Growing): This region experiences significant growth with: o Lower manufacturing costs compared to North America and Europe. o Rising government support for R&D and domestic pharma industries (China, India). o Aging population driving demand for new drugs. • Europe (Quality Focus): A mature market known for: o Strong presence of global CMO companies with advanced capabilities. o Emphasis on high-quality manufacturing and strict regulatory compliance. o Potential limitations due to complex regulations and high labor costs. • Emerging Players (Latin America, Middle East & Africa): These regions show promise with: o Growing economies and rising healthcare expenditure. o Untapped potential for CMO services. o Need for affordable drug access, potentially favoring local manufacturing. Key Developments • Facility Expansion in Asia: WuXi AppTec, a major Chinese CMO, announced a $500 million expansion of its manufacturing facility in Massachusetts, USA in April 2024. This highlights the growing demand for CMO services from established players in North America. • Focus on Gene Therapy: Lonza, a leading Swiss CMO, partnered with a biotech company in Europe in February 2024 to develop and manufacture a novel gene therapy treatment for a rare disease. This signifies the increasing involvement of CMOs in innovative areas of pharmaceuticals. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Catalent DPx Lonza Piramal Healthcare Aenova Jubilant Famar Boehringer Ingelheim Fareva Holding AbbVie Nipro Corp Vetter Sopharma DPT Laboratories Recipharm NextPharma Dishman Aesica
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Contract Pharmaceutical Manufacturing Market Size 2019-2030
- 2.1.2 Contract Pharmaceutical Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
- 2.2 Contract Pharmaceutical Manufacturing Segment by Type
- 2.2.1 Oral
- 2.2.2 Injectable
- 2.2.3 API
- 2.2.4 Other
- 2.3 Contract Pharmaceutical Manufacturing Market Size by Type
- 2.3.1 Contract Pharmaceutical Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
- 2.4 Contract Pharmaceutical Manufacturing Segment by Application
- 2.4.1 Large Enterprise
- 2.4.2 Small Medium Enterprise
- 2.5 Contract Pharmaceutical Manufacturing Market Size by Application
- 2.5.1 Contract Pharmaceutical Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
- 3 Contract Pharmaceutical Manufacturing Market Size by Player
- 3.1 Contract Pharmaceutical Manufacturing Market Size Market Share by Players
- 3.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Players (2019-2024)
- 3.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2019-2024)
- 3.2 Global Contract Pharmaceutical Manufacturing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Contract Pharmaceutical Manufacturing by Regions
- 4.1 Contract Pharmaceutical Manufacturing Market Size by Regions (2019-2024)
- 4.2 Americas Contract Pharmaceutical Manufacturing Market Size Growth (2019-2024)
- 4.3 APAC Contract Pharmaceutical Manufacturing Market Size Growth (2019-2024)
- 4.4 Europe Contract Pharmaceutical Manufacturing Market Size Growth (2019-2024)
- 4.5 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024)
- 5.2 Americas Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024)
- 5.3 Americas Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Contract Pharmaceutical Manufacturing Market Size by Region (2019-2024)
- 6.2 APAC Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024)
- 6.3 APAC Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Contract Pharmaceutical Manufacturing by Country (2019-2024)
- 7.2 Europe Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024)
- 7.3 Europe Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Contract Pharmaceutical Manufacturing by Region (2019-2024)
- 8.2 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Contract Pharmaceutical Manufacturing Market Forecast
- 10.1 Global Contract Pharmaceutical Manufacturing Forecast by Regions (2025-2030)
- 10.1.1 Global Contract Pharmaceutical Manufacturing Forecast by Regions (2025-2030)
- 10.1.2 Americas Contract Pharmaceutical Manufacturing Forecast
- 10.1.3 APAC Contract Pharmaceutical Manufacturing Forecast
- 10.1.4 Europe Contract Pharmaceutical Manufacturing Forecast
- 10.1.5 Middle East & Africa Contract Pharmaceutical Manufacturing Forecast
- 10.2 Americas Contract Pharmaceutical Manufacturing Forecast by Country (2025-2030)
- 10.2.1 United States Contract Pharmaceutical Manufacturing Market Forecast
- 10.2.2 Canada Contract Pharmaceutical Manufacturing Market Forecast
- 10.2.3 Mexico Contract Pharmaceutical Manufacturing Market Forecast
- 10.2.4 Brazil Contract Pharmaceutical Manufacturing Market Forecast
- 10.3 APAC Contract Pharmaceutical Manufacturing Forecast by Region (2025-2030)
- 10.3.1 China Contract Pharmaceutical Manufacturing Market Forecast
- 10.3.2 Japan Contract Pharmaceutical Manufacturing Market Forecast
- 10.3.3 Korea Contract Pharmaceutical Manufacturing Market Forecast
- 10.3.4 Southeast Asia Contract Pharmaceutical Manufacturing Market Forecast
- 10.3.5 India Contract Pharmaceutical Manufacturing Market Forecast
- 10.3.6 Australia Contract Pharmaceutical Manufacturing Market Forecast
- 10.4 Europe Contract Pharmaceutical Manufacturing Forecast by Country (2025-2030)
- 10.4.1 Germany Contract Pharmaceutical Manufacturing Market Forecast
- 10.4.2 France Contract Pharmaceutical Manufacturing Market Forecast
- 10.4.3 UK Contract Pharmaceutical Manufacturing Market Forecast
- 10.4.4 Italy Contract Pharmaceutical Manufacturing Market Forecast
- 10.4.5 Russia Contract Pharmaceutical Manufacturing Market Forecast
- 10.5 Middle East & Africa Contract Pharmaceutical Manufacturing Forecast by Region (2025-2030)
- 10.5.1 Egypt Contract Pharmaceutical Manufacturing Market Forecast
- 10.5.2 South Africa Contract Pharmaceutical Manufacturing Market Forecast
- 10.5.3 Israel Contract Pharmaceutical Manufacturing Market Forecast
- 10.5.4 Turkey Contract Pharmaceutical Manufacturing Market Forecast
- 10.5.5 GCC Countries Contract Pharmaceutical Manufacturing Market Forecast
- 10.6 Global Contract Pharmaceutical Manufacturing Forecast by Type (2025-2030)
- 10.7 Global Contract Pharmaceutical Manufacturing Forecast by Application (2025-2030)
- 11 Key Players Analysis
- 11.1 Catalent
- 11.1.1 Catalent Company Information
- 11.1.2 Catalent Contract Pharmaceutical Manufacturing Product Offered
- 11.1.3 Catalent Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Catalent Main Business Overview
- 11.1.5 Catalent Latest Developments
- 11.2 DPx
- 11.2.1 DPx Company Information
- 11.2.2 DPx Contract Pharmaceutical Manufacturing Product Offered
- 11.2.3 DPx Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 DPx Main Business Overview
- 11.2.5 DPx Latest Developments
- 11.3 Lonza
- 11.3.1 Lonza Company Information
- 11.3.2 Lonza Contract Pharmaceutical Manufacturing Product Offered
- 11.3.3 Lonza Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Lonza Main Business Overview
- 11.3.5 Lonza Latest Developments
- 11.4 Piramal Healthcare
- 11.4.1 Piramal Healthcare Company Information
- 11.4.2 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Offered
- 11.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 Piramal Healthcare Main Business Overview
- 11.4.5 Piramal Healthcare Latest Developments
- 11.5 Aenova
- 11.5.1 Aenova Company Information
- 11.5.2 Aenova Contract Pharmaceutical Manufacturing Product Offered
- 11.5.3 Aenova Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 Aenova Main Business Overview
- 11.5.5 Aenova Latest Developments
- 11.6 Jubilant
- 11.6.1 Jubilant Company Information
- 11.6.2 Jubilant Contract Pharmaceutical Manufacturing Product Offered
- 11.6.3 Jubilant Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 Jubilant Main Business Overview
- 11.6.5 Jubilant Latest Developments
- 11.7 Famar
- 11.7.1 Famar Company Information
- 11.7.2 Famar Contract Pharmaceutical Manufacturing Product Offered
- 11.7.3 Famar Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 Famar Main Business Overview
- 11.7.5 Famar Latest Developments
- 11.8 Boehringer Ingelheim
- 11.8.1 Boehringer Ingelheim Company Information
- 11.8.2 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Offered
- 11.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 Boehringer Ingelheim Main Business Overview
- 11.8.5 Boehringer Ingelheim Latest Developments
- 11.9 Fareva Holding
- 11.9.1 Fareva Holding Company Information
- 11.9.2 Fareva Holding Contract Pharmaceutical Manufacturing Product Offered
- 11.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Fareva Holding Main Business Overview
- 11.9.5 Fareva Holding Latest Developments
- 11.10 AbbVie
- 11.10.1 AbbVie Company Information
- 11.10.2 AbbVie Contract Pharmaceutical Manufacturing Product Offered
- 11.10.3 AbbVie Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 AbbVie Main Business Overview
- 11.10.5 AbbVie Latest Developments
- 11.11 Nipro Corp
- 11.11.1 Nipro Corp Company Information
- 11.11.2 Nipro Corp Contract Pharmaceutical Manufacturing Product Offered
- 11.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 Nipro Corp Main Business Overview
- 11.11.5 Nipro Corp Latest Developments
- 11.12 Vetter
- 11.12.1 Vetter Company Information
- 11.12.2 Vetter Contract Pharmaceutical Manufacturing Product Offered
- 11.12.3 Vetter Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 Vetter Main Business Overview
- 11.12.5 Vetter Latest Developments
- 11.13 Sopharma
- 11.13.1 Sopharma Company Information
- 11.13.2 Sopharma Contract Pharmaceutical Manufacturing Product Offered
- 11.13.3 Sopharma Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 Sopharma Main Business Overview
- 11.13.5 Sopharma Latest Developments
- 11.14 DPT Laboratories
- 11.14.1 DPT Laboratories Company Information
- 11.14.2 DPT Laboratories Contract Pharmaceutical Manufacturing Product Offered
- 11.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.14.4 DPT Laboratories Main Business Overview
- 11.14.5 DPT Laboratories Latest Developments
- 11.15 Recipharm
- 11.15.1 Recipharm Company Information
- 11.15.2 Recipharm Contract Pharmaceutical Manufacturing Product Offered
- 11.15.3 Recipharm Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.15.4 Recipharm Main Business Overview
- 11.15.5 Recipharm Latest Developments
- 11.16 NextPharma
- 11.16.1 NextPharma Company Information
- 11.16.2 NextPharma Contract Pharmaceutical Manufacturing Product Offered
- 11.16.3 NextPharma Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.16.4 NextPharma Main Business Overview
- 11.16.5 NextPharma Latest Developments
- 11.17 Dishman
- 11.17.1 Dishman Company Information
- 11.17.2 Dishman Contract Pharmaceutical Manufacturing Product Offered
- 11.17.3 Dishman Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.17.4 Dishman Main Business Overview
- 11.17.5 Dishman Latest Developments
- 11.18 Aesica
- 11.18.1 Aesica Company Information
- 11.18.2 Aesica Contract Pharmaceutical Manufacturing Product Offered
- 11.18.3 Aesica Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.18.4 Aesica Main Business Overview
- 11.18.5 Aesica Latest Developments
- 12 Research Findings and Conclusion
Table 1. Contract Pharmaceutical Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injectable
Table 4. Major Players of API
Table 5. Major Players of Other
Table 6. Contract Pharmaceutical Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
Table 9. Contract Pharmaceutical Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
Table 12. Global Contract Pharmaceutical Manufacturing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Player (2019-2024)
Table 14. Contract Pharmaceutical Manufacturing Key Players Head office and Products Offered
Table 15. Contract Pharmaceutical Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Contract Pharmaceutical Manufacturing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Regions (2019-2024)
Table 20. Global Contract Pharmaceutical Manufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Contract Pharmaceutical Manufacturing Market Size Market Share by Country (2019-2024)
Table 24. Americas Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
Table 26. Americas Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
Table 28. APAC Contract Pharmaceutical Manufacturing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Contract Pharmaceutical Manufacturing Market Size Market Share by Region (2019-2024)
Table 30. APAC Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
Table 32. APAC Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
Table 34. Europe Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Contract Pharmaceutical Manufacturing Market Size Market Share by Country (2019-2024)
Table 36. Europe Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
Table 38. Europe Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Contract Pharmaceutical Manufacturing
Table 47. Key Market Challenges & Risks of Contract Pharmaceutical Manufacturing
Table 48. Key Industry Trends of Contract Pharmaceutical Manufacturing
Table 49. Global Contract Pharmaceutical Manufacturing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Contract Pharmaceutical Manufacturing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Contract Pharmaceutical Manufacturing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Contract Pharmaceutical Manufacturing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Catalent Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 54. Catalent Contract Pharmaceutical Manufacturing Product Offered
Table 55. Catalent Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Catalent Main Business
Table 57. Catalent Latest Developments
Table 58. DPx Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 59. DPx Contract Pharmaceutical Manufacturing Product Offered
Table 60. DPx Main Business
Table 61. DPx Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. DPx Latest Developments
Table 63. Lonza Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 64. Lonza Contract Pharmaceutical Manufacturing Product Offered
Table 65. Lonza Main Business
Table 66. Lonza Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Lonza Latest Developments
Table 68. Piramal Healthcare Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 69. Piramal Healthcare Contract Pharmaceutical Manufacturing Product Offered
Table 70. Piramal Healthcare Main Business
Table 71. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Piramal Healthcare Latest Developments
Table 73. Aenova Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 74. Aenova Contract Pharmaceutical Manufacturing Product Offered
Table 75. Aenova Main Business
Table 76. Aenova Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Aenova Latest Developments
Table 78. Jubilant Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 79. Jubilant Contract Pharmaceutical Manufacturing Product Offered
Table 80. Jubilant Main Business
Table 81. Jubilant Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Jubilant Latest Developments
Table 83. Famar Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 84. Famar Contract Pharmaceutical Manufacturing Product Offered
Table 85. Famar Main Business
Table 86. Famar Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Famar Latest Developments
Table 88. Boehringer Ingelheim Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 89. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Offered
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Fareva Holding Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 94. Fareva Holding Contract Pharmaceutical Manufacturing Product Offered
Table 95. Fareva Holding Main Business
Table 96. Fareva Holding Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Fareva Holding Latest Developments
Table 98. AbbVie Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 99. AbbVie Contract Pharmaceutical Manufacturing Product Offered
Table 100. AbbVie Main Business
Table 101. AbbVie Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. AbbVie Latest Developments
Table 103. Nipro Corp Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 104. Nipro Corp Contract Pharmaceutical Manufacturing Product Offered
Table 105. Nipro Corp Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Nipro Corp Main Business
Table 107. Nipro Corp Latest Developments
Table 108. Vetter Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 109. Vetter Contract Pharmaceutical Manufacturing Product Offered
Table 110. Vetter Main Business
Table 111. Vetter Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Vetter Latest Developments
Table 113. Sopharma Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 114. Sopharma Contract Pharmaceutical Manufacturing Product Offered
Table 115. Sopharma Main Business
Table 116. Sopharma Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Sopharma Latest Developments
Table 118. DPT Laboratories Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 119. DPT Laboratories Contract Pharmaceutical Manufacturing Product Offered
Table 120. DPT Laboratories Main Business
Table 121. DPT Laboratories Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. DPT Laboratories Latest Developments
Table 123. Recipharm Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 124. Recipharm Contract Pharmaceutical Manufacturing Product Offered
Table 125. Recipharm Main Business
Table 126. Recipharm Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Recipharm Latest Developments
Table 128. NextPharma Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 129. NextPharma Contract Pharmaceutical Manufacturing Product Offered
Table 130. NextPharma Main Business
Table 131. NextPharma Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. NextPharma Latest Developments
Table 133. Dishman Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 134. Dishman Contract Pharmaceutical Manufacturing Product Offered
Table 135. Dishman Main Business
Table 136. Dishman Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Dishman Latest Developments
Table 138. Aesica Details, Company Type, Contract Pharmaceutical Manufacturing Area Served and Its Competitors
Table 139. Aesica Contract Pharmaceutical Manufacturing Product Offered
Table 140. Aesica Main Business
Table 141. Aesica Contract Pharmaceutical Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Aesica Latest Developments
Related Reports
Allows one individual to access the purchased report Read More
Allows all employees of an organization to access the purchased report. Internal sharing only Read More
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (27 July, 2024)
- Notify To Team (27 July, 2024)
- Report updation (28 July, 2024)
- Report Quality Check (28 July, 2024)
- Report Dispatch (29 July, 2024)
- Hard Copy
Recently Viewed Products
Global Contract Pharmaceutical Manufacturing Market Growth (Status and Outlook) 2024-2030
We are friendly and approachable, give us a call.